M3, Inc.
MTHRF
Other OTC8.55
USD
- -
- -
ISIN
JP3435750009
Return %
Stock
S&P500
1Y
-33.96
26.53
3Y
-63.76
76.60
5Y
-86.90
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Itaru Tanimura
- Full Time Employees
- 12,100
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- Akasaka Intercity Tokyo Japan 107-0052
- IPO Date
- Sep 9, 2014
- Website
- corporate.m3.com
- Similar Companies
- Business
- M3, Inc. is a Tokyo-based company founded in 2000 that operates principally in the healthcare sector by providing internet-based medical-related services and solutions globally. The company’s core offerings include medical platforms such as its specialized medical professional site m3.com; evidence solutions encompassing contract research organization (CRO) services supporting clinical development and site management organization (SMO) for clinical trial operations; career and job placement services for physicians and pharmacists; and healthcare digital technologies including electronic health records (EHR) systems and cloud-based clinic operation solutions. M3 serves healthcare professionals, pharmaceutical companies, and health organizations primarily in Japan, the U.S., Europe, India, and Asia. Recent major developments include strategic acquisitions such as equity stakes in EWEL Inc. and Limbic Digital Media Pty Ltd in early 2025 to enhance digital healthcare solutions and content; expansion of research and marketing analytics capabilities through acquisitions from Kantar Group in Europe and the U.S.; a partnership with Sony and NTT DOCOMO focused on innovative healthcare ICT/IoT integration including COVID-19 related AI diagnosis support; and alliances with pharmaceutical companies like Nippon Boehringer Ingelheim for AI-driven diagnostic support tools. M3 also launched new services such as the “M3 DigiKar Smart” cloud platform for clinic operation management and introduced the “White Jack Project,” aimed at preventive medicine. Additionally, a subsidiary was newly listed on the Tokyo Stock Exchange Growth Market, underscoring M3’s business expansion and financial market activities. M3 operates through multiple segments, including Medical Platforms, Evidence Solutions, Career & Site Solutions, and digital healthcare services, targeting a broad client base of medical practitioners, healthcare providers, pharmaceutical firms, and allied health businesses. The company’s headquarters is in Minato-ku, Tokyo, and it maintains a strong presence in international markets through subsidiaries and strategic alliances. M3 continues to leverage technology, including AI and cloud platforms, to drive integrated healthcare solutions and maintain leadership in medical digital platforms and clinical research services. The company’s ongoing investments in innovation and partnerships reflect its commitment to expanding its healthcare ecosystem globally.
Invesco EQV International Equity Fund Q1 2026 Portfolio Review
M3 (OTCMKTS:MTHRF) Trading Up 1.7% – Time to Buy?